All Updates

All Updates

icon
Filter
Funding
BioPhy raises USD 4.5 million in seed funding
AI Drug Discovery
Nov 7, 2023
This week:
Product updates
Nintendo ventures into MMOs with new Switch Online game playtest
Metaverse Experience Platforms
Yesterday
Product updates
HP releases texture library for 3D printing with CoreTechnologie 4D Additive
Additive Manufacturing
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Smart Factory
Oct 21, 2024
Product updates
xAI launches API for third-party developers to access Grok models
Foundation Models
Oct 21, 2024
Partnerships
Nava Benefits partners with OpenAI to launch AI-powered benefits assistant
Foundation Models
Oct 21, 2024
Product updates
IBM releases Granite 3.0 AI models for enterprise use
Foundation Models
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Foundation Models
Oct 21, 2024
M&A
Inflection AI acquires Boundaryless for undisclosed sum to accelerate enterprise AI deployments
Foundation Models
Oct 21, 2024
Industry news
News Corp sues Perplexity AI for alleged copyright infringement
Generative AI Applications
Oct 21, 2024
Product updates
Haiper debuts new video generation model
Generative AI Applications
Oct 21, 2024
AI Drug Discovery

AI Drug Discovery

Nov 7, 2023

BioPhy raises USD 4.5 million in seed funding

Funding

  • Philadelphia-based AI drug discovery company BioPhy has raised USD 4.5 million in seed funding led by Metrodora Ventures, with participation from Audere Capital and individual investors, including Jeff Marrazzo, the co-founder of Spark Therapeutics.

  • The funds will be used to advance BioPhy's AI platform further, expand the company’s R&D operations, and expand its business reach.

  • BioPhy leverages its patent-pending predictive AI engine BiologicAI to identify, develop, and test drugs and also aids in the improvement of clinical trial outcomes, decreasing trial failure rates and speeding up drug development. BioPhyRx, a part of BioPhy, is a GenAI solution designed to create a centralized area to access scientific and regulatory resources. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.